Form 4: Medicine Man Technologies Director Acquires Shares as Compensation

Sentiment:

SEC Form 4 Filing


Paul Joseph Montalbano, a director of Medicine Man Technologies, Inc., acquired 67,308 shares of common stock as compensation for board service.

Summary

  • Paul Joseph Montalbano, a director at Medicine Man Technologies, Inc. [SHWZ], acquired 67,308 shares of common stock on June 28, 2024.
  • The shares were granted as compensation for his service on the board of directors.
  • The aggregate value of the shares was $26,250, based on the closing price of the common stock on the OTCQX Best Market on June 28, 2024.
  • Following the transaction, Montalbano directly owns 320,728 shares of Medicine Man Technologies, Inc.

Sentiment

Score: 6

Explanation: Neutral sentiment. The transaction is a standard part of director compensation and doesn't necessarily indicate a significant positive or negative outlook for the company.

Positives

  • The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future.

Industry Context

This type of transaction is common for directors receiving stock options or grants as part of their compensation packages. It aligns the director's interests with those of the shareholders.

Stakeholder Impact

  • The transaction increases the director's stake in the company, aligning their interests with those of other shareholders.

Key Dates

DateDescription
06/28/2024Date of the transaction: Paul J. Montalbano acquired 67,308 shares of common stock.
07/02/2024Date of the Form 4 filing.

Keywords

Medicine Man Technologies, SHWZ, director, Paul Joseph Montalbano, stock acquisition, Form 4, compensation, OTCQX Best Market, beneficial ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.